For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Penn Live
Harrisburg is taking a wrong approach to drug pricing | PennLive letters
CEI’s Joel Zinberg was cited in a Penn Live article on Pharmacy Benefit Managers: Joel Zinberg from the Competitive Enterprise Institute (CEI) explains, “PBMs enhance…
Politico
Biden’s got a plan to protect science from Trump
CEI’s Joel Zinberg was cited in Politico on the obstacles Trump faces with the NIH: Trump should have no illusions about what he’s up against,…
Blog
New FDA lab tests rule could bankrupt small labs
Yesterday the Food and Drug Administration (FDA) announced that on May 6 it will promulgate a rule under its authority to regulate medical devices.
Search Posts
CEI Planet
CEI Planet: September 2004
Full Document Available in PDF Tech Regulation Done Right, by Braden Cox…
Citation
Downsize Her
Products
Confronting the Malaria Threat
Full Document Available in PDF Ninety years ago, a Congressional Committee held a hearing…
Products
Ketchup: More than a Vegetable?
The organic food industry got an unexpected boost from the Democratic National Convention this past July. The surprise came from how the candidate’s wife, Teresa…
Op-Eds
Mr. Rifkin’s Pipe Dream
Professional worrier Jeremy Rifkin's pronouncements always remind me of the characterization by one-time Speaker of the House of Representatives Thomas B. Reed of…
Op-Eds
Back to School for Pests
As students return to school this fall, parents will again worry about new illnesses as kids come in contact with more cold and…